Passa al contenuto
Merck

Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a).

Bioorganic & medicinal chemistry letters (2010-04-07)
P Douglas Boatman, Thomas O Schrader, Michelle Kasem, Benjamin R Johnson, Philip J Skinner, Jae-Kyu Jung, Jerry Xu, Martin C Cherrier, Peter J Webb, Graeme Semple, Carleton R Sage, Jens Knudsen, Ruoping Chen, Andrew K Taggart, Ester Carballo-Jane, Jeremy G Richman
ABSTRACT

Tricyclic pyrazole tetrazoles which are potent partial agonists of the high affinity niacin receptor, GPR109a, have been discovered and optimized. One of these compounds has proven to be effective at lowering free fatty acids in vitro and in vivo.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Acido nicotinico, ≥99.5% (HPLC)
Sigma-Aldrich
Acido nicotinico, ≥98%
Supelco
Acido nicotinico, analytical standard
Sigma-Aldrich
Acido nicotinico, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Acido nicotinico, meets USP testing specifications